ADMA Biologics
ADMA
ADMA
67 hedge funds and large institutions have $136M invested in ADMA Biologics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 56 → 67 (+11)
10.97% more ownership
Funds ownership: 48.1% → 59.06% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
67
Holding in Top 10
1
Calls
$303K
Puts
$128K
Top Buyers
| 1 | +$19.3M | |
| 2 | +$7.51M | |
| 3 | +$4.32M | |
| 4 |
BlackRock
New York
|
+$3.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.04M |
Top Sellers
| 1 | -$2.83M | |
| 2 | -$207K | |
| 3 | -$146K | |
| 4 |
DG
Delek Group
Herzliya,
Israel
|
-$114K |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
-$96.8K |